A Phase III, Randomized, Multicenter, Parallel-group Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
Condition: Asthma Interventions: Drug: Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals; Drug: ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK; Drug: Placebo Sponsor: Respirent Pharmaceuticals Co Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2018 Category: Research Source Type: clinical trials
A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
Condition: Asthma Interventions: Drug: Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals; Drug: ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK; Drug: Placebo Sponsor: Respirent Pharmaceuticals Co Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2018 Category: Research Source Type: clinical trials
A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50
Condition: Asthma Interventions: Drug: Test Product; Drug: Reference Product; Drug: Placebo Sponsor: Amneal Ireland Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2018 Category: Research Source Type: clinical trials